Correlation Between Vertex Pharmaceuticals and SCANDION ONC

Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and SCANDION ONC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and SCANDION ONC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vertex Pharmaceuticals Incorporated and SCANDION ONC DK 0735, you can compare the effects of market volatilities on Vertex Pharmaceuticals and SCANDION ONC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of SCANDION ONC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and SCANDION ONC.

Diversification Opportunities for Vertex Pharmaceuticals and SCANDION ONC

0.06

Correlation Coefficient

Vertex Pharmaceuticals  SCANDION ONC

Significant diversification

The 3 months correlation between Vertex and SCANDION is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals Incorpo and SCANDION ONC DK 0735 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCANDION ONC DK and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals Incorporated are associated (or correlated) with SCANDION ONC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCANDION ONC DK has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and SCANDION ONC go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and SCANDION ONC

Assuming the 90 days horizon Vertex Pharmaceuticals Incorporated is expected to generate 0.76 times more return on investment than SCANDION ONC. However, Vertex Pharmaceuticals Incorporated is 1.31 times less risky than SCANDION ONC. It trades about -0.15 of its potential returns per unit of risk. SCANDION ONC DK 0735 is currently generating about -0.33 per unit of risk. If you would invest  44,070  in Vertex Pharmaceuticals Incorporated on October 15, 2024 and sell it today you would lose (4,225) from holding Vertex Pharmaceuticals Incorporated or give up 9.59% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	93.75%
Values	Daily Returns

Vertex Pharmaceuticals Incorpo  vs.  SCANDION ONC DK 0735

Vertex Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vertex Pharmaceuticals Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

SCANDION ONC DK

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SCANDION ONC DK 0735 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Vertex Pharmaceuticals and SCANDION ONC

The main advantage of trading using opposite Vertex Pharmaceuticals and SCANDION ONC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, SCANDION ONC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCANDION ONC will offset losses from the drop in SCANDION ONC's long position.

The idea behind Vertex Pharmaceuticals Incorporated and SCANDION ONC DK 0735 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.